Oncology & Cancer

For brain tumors, origins matter

(Medical Xpress)—Since stem cells and progenitor cells are regulated by different growth factors, brain tumors arising from these cells might respond differently to different therapies. Researchers at Sanford-Burnham Medical ...

Oncology & Cancer

Intracranial tumors can be resected safely in elderly

(HealthDay)—Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online ...

Oncology & Cancer

Researchers make breakthrough on immune system and brain tumors

In what could be a breakthrough in the treatment of deadly brain tumors, a team of researchers from Barrow Neurological Institute and Arizona State University has discovered that the immune system reacts differently to different ...

Oncology & Cancer

DNA deletions promote cancer, collateral damage makes it vulnerable

Genomic deletions promote cancer by carving up or eliminating tumor-suppressor genes, but now scientists report in the journal Nature that the collateral damage they inflict on neighboring genes exposes cancer cells to vulnerabilities ...

Oncology & Cancer

Study suggests new treatment target for glioblastoma multiforme

A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target for future ...

page 12 from 17